Xue Zhu
- Molecular Biology top 10%
- Advanced biosensing and bioanalysis techniques 24
- RNA Interference and Gene Delivery 12
- DNA and Nucleic Acid Chemistry 10
- Natural product bioactivities and synthesis 9
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- Ophthalmology top 5%
- Retinal Diseases and Treatments 7
-
- Ginkgo biloba and Cashew Applications 8
-
- Neuroinflammation and Neurodegeneration Mechanisms 8
In The Last Decade
Xue Zhu
90 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 39
- Molecular Biology 1.3k
- Cancer Research 259
- Ophthalmology 152
- Complementary and alternative medicine 133
Countries citing papers authored by Xue Zhu
This map shows the geographic impact of Xue Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Zhu more than expected).
Fields of papers citing papers by Xue Zhu
This network shows the impact of papers produced by Xue Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Zhu. The network helps show where Xue Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 37 | |
| 9 | 2019 | 11 | |
| 10 | 2019 | 23 | |
| 11 | 2018 | 46 | |
| 12 | 2018 | 23 | |
| 13 | 2017 | 67 | |
| 14 | 2015 | 11 | |
| 15 | Paeoniflorin attenuates Aβ25-35-induced neurotoxicity in PC12 cells by preventing mitochondrial dysfunction. | 2014 | 27 |
| 16 | 2014 | 1 | |
| 17 | 2014 | 64 | |
| 18 | 2013 | 34 | |
| 19 | 2013 | 91 | |
| 20 | 2012 | 54 |
About Xue Zhu
Xue Zhu is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Neurology, having authored 92 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (24 papers), RNA Interference and Gene Delivery (12 papers), DNA and Nucleic Acid Chemistry (10 papers), Natural product bioactivities and synthesis (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Ginkgo biloba and Cashew Applications (8 papers), MicroRNA in disease regulation (8 papers) and Retinal Diseases and Treatments (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (39 citations), Molecular Biology (1.3k citations) and Cancer Research (259 citations). Xue Zhu has collaborated with scholars based in China, Australia and Fiji. Frequent co-authors include Kai Zhang, Ke Wang, Fanfan Zhou, Ling Zhu, Minhao Xie, Biao Huang, Ke Wang, Ke Wang, Yongxiang Yin and Yong Yao. Their work appears in journals such as Analytical Chemistry, Chemical Communications and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.